NEW YORK (GenomeWeb) – New research suggests that a single biopsy may not be sufficient for profiling immune cell activity in the microenvironment of non-small cell lung carcinoma (NSCLC) tumors.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.